Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,552 | 30 | 70.4% |
| Food and Beverage | $16,757 | 536 | 15.6% |
| Travel and Lodging | $9,606 | 25 | 9.0% |
| Consulting Fee | $4,930 | 2 | 4.6% |
| Education | $455.17 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $95,370 | 226 | $0 (2024) |
| UCB, Inc. | $1,544 | 10 | $0 (2024) |
| GENZYME CORPORATION | $1,409 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $1,256 | 62 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,071 | 23 | $0 (2024) |
| Lilly USA, LLC | $647.18 | 22 | $0 (2024) |
| Galderma Laboratories, L.P. | $592.54 | 18 | $0 (2024) |
| PFIZER INC. | $578.80 | 30 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $578.63 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $542.18 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,616 | 85 | ABBVIE INC. ($545.63) |
| 2023 | $3,235 | 66 | UCB, Inc. ($1,201) |
| 2022 | $15,588 | 93 | ABBVIE INC. ($13,942) |
| 2021 | $27,442 | 84 | AbbVie Inc. ($26,445) |
| 2020 | $9,505 | 38 | AbbVie Inc. ($8,717) |
| 2019 | $44,413 | 111 | AbbVie, Inc. ($42,940) |
| 2018 | $3,181 | 77 | AbbVie, Inc. ($1,715) |
| 2017 | $1,321 | 46 | AbbVie, Inc. ($473.53) |
All Payment Transactions
600 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.73 | General |
| Category: Immunology | ||||||
| 12/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.87 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.18 | General |
| Category: Immunology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $116.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.62 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.55 | General |
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,752 | 6,600 | $880,580 | $304,133 |
| 2022 | 28 | 3,911 | 6,909 | $981,385 | $352,848 |
| 2021 | 25 | 3,461 | 6,160 | $804,960 | $313,619 |
| 2020 | 21 | 2,822 | 4,810 | $553,505 | $204,835 |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 734 | 956 | $143,400 | $58,150 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 553 | $110,600 | $49,339 | 44.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 530 | 700 | $157,500 | $44,326 | 28.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 278 | 343 | $60,025 | $25,703 | 42.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 269 | 591 | $59,100 | $22,723 | 38.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 86 | 96 | $40,800 | $21,037 | 51.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 480 | 615 | $76,875 | $19,587 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 340 | 1,945 | $68,075 | $9,606 | 14.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $18,975 | $7,672 | 40.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 59 | 70 | $24,500 | $6,756 | 27.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 42 | 48 | $26,400 | $6,079 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $16,400 | $5,751 | 35.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 43 | $10,750 | $4,715 | 43.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 45 | 46 | $9,375 | $4,272 | 45.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 81 | $10,125 | $3,209 | 31.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $5,850 | $2,958 | 50.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 30 | 35 | $7,000 | $2,812 | 40.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 16 | 16 | $6,400 | $1,746 | 27.3% |
| 69100 | Biopsy of ear | Office | 2023 | 31 | 33 | $6,600 | $1,538 | 23.3% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 32 | 32 | $4,800 | $1,521 | 31.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $5,225 | $1,271 | 24.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $4,125 | $1,269 | 30.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 28 | 37 | $3,700 | $1,180 | 31.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,950 | $560.24 | 28.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 25 | $750.00 | $250.70 | 33.4% |
About Dr. Kristen Stewart, M.D
Dr. Kristen Stewart, M.D is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154397370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristen Stewart, M.D has received a total of $107,300 in payments from pharmaceutical and medical device companies, with $2,616 received in 2024. These payments were reported across 600 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,552).
As a Medicare-enrolled provider, Stewart has provided services to 13,946 Medicare beneficiaries, totaling 24,479 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 02/27/2006
- Last Updated 04/11/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1154397370
Products in Payments
- HUMIRA (Biological) $22,983
- Skyrizi (Biological) $20,746
- Humira (Biological) $19,135
- SKYRIZI (Biological) $13,529
- DUPIXENT (Biological) $1,432
- RINVOQ (Biological) $1,397
- TREMFYA (Drug) $1,149
- Tremfya (Drug) $578.83
- EUCRISA (Drug) $578.80
- TALTZ (Drug) $523.74
- LIBTAYO (Biological) $415.17
- Sotyktu (Drug) $412.10
- Otezla (Drug) $383.44
- COSENTYX (Biological) $367.51
- Zoryve (Drug) $271.57
- DUPIXENT (Drug) $262.93
- EPIDUO FORTE (Drug) $256.36
- ADBRY (Biological) $251.52
- OPZELURA (Drug) $241.00
- Enbrel (Biological) $231.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dr. Douglas Robins, Md, MD
Dermatology — Payments: $24,873
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
John Morello, M.d, M.D
Dermatology — Payments: $12,575